Effect of a chosen drug of Persian medicine on dysuria during radiotherapy for localized prostate cancer
Not Applicable
- Conditions
- prostate cancer.Malignant neoplasm of prostate
- Registration Number
- IRCT2012100711026N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
patients who are planed radiotherapy with impression of prostate adenocarcinema and signed informed consent, those who are able to Express dysuria and do not have not have foley catheter.
exclusion criteria: Drug or placebo sensitivity and positive urine culture indicative of infection.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dysuria. Timepoint: Weekly during radiotherapy. Method of measurement: A modified IPSS (International Prostate Symptom Score).
- Secondary Outcome Measures
Name Time Method Dysuria severity. Timepoint: Weekly during radiotherapy. Method of measurement: Visual Analog Scale 0-10.